ADVERTISEMENT

Impel Neuropharma Contact Us

833-878-3437 WEBImpel Pharmaceuticals is actively considering partnerships, collaborations and licensing opportunities to explore the therapeutic potential of our technology and expertise with both small and large molecules. Impel …

See Also: Home Phone PreviewShow details

ADVERTISEMENT

WEBImpel Pharmaceuticals is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules and formulations. As a result, Impel Pharmaceuticals’ therapies have the potential to …

See Also: Phone Number PreviewShow details

WEBApr 25, 2022 · Impel Neuropharma Announces Company Will Now Be Known as Impel Pharmaceuticals to Reflect Corporate Transformation Contact: Media Relations:

See Also: Contact Support PreviewShow details

WEBImpel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's …

Funding: $268.9 million
Ticker: IMPL
Revenue: $19 million

See Also: Contact Support PreviewShow details

WEBImpel Pharmaceuticals 9,350 followers on LinkedIn. Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing

See Also: Phone Number PreviewShow details

ADVERTISEMENT

WEBPhone Number 2067261217. Impel NeuroPharma is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize …

See Also: Phone Number PreviewShow details

WEBImpel NeuroPharma has 9 current employee profiles, including Co-Founder, Chief Scientific Officer, Chief Technology, and Development Officer John Hoekman. Impel …

See Also: Contact Support PreviewShow details

WEBApr 25, 2022 · Impel Celebrates Its One-Year Anniversary as a Public Company Today at the Nasdaq Stock Market Closing Bell Ceremony Starting at 3:45 p.m. EDTSEATTLE, …

See Also: Dts Tmc Assistance Phone Number PreviewShow details

WEBSep 3, 2021 · The FDA has approved Impel NeuroPharma’s INP104 nasal spray for the acute treatment of migraine headaches with or without aura in adults. Marketed as …

See Also: Atm PreviewShow details

WEBFeb 10, 2021 · About Impel NeuroPharma Impel NeuroPharma, Inc. is a privately held, Seattle-based biopharmaceutical company focused on developing transformative …

See Also: Phone Number PreviewShow details

WEBMar 1, 2021 · Mr. Paolillo joins Impel NeuroPharma from Kyowa Kirin Inc., the North American affiliate of Kyowa Kirin Co. Ltd., a global specialty pharmaceutical company …

See Also: Liat Airlines Phone Number PreviewShow details

WEBNov 9, 2020 · About Impel NeuroPharma: Impel NeuroPharma, Inc. is a privately held, Seattle-based biopharmaceutical company focused on developing transformative …

See Also: Phone Number PreviewShow details

WEBJan 20, 2021 · Impel NeuroPharma, Inc. is a privately held, Seattle-based biopharmaceutical company focused on developing transformative therapies for people …

See Also: Food PreviewShow details

ADVERTISEMENT

WEB(Note: Impel NeuroPharma priced its IPO at $15 – the mid-point of its $14-to-$16 range – on 5.33 million shares to raise $79.95 million.) Industry: PHARMACEUTICAL …

See Also: Phone Number PreviewShow details

WEBFeb 10, 2021 · Impel adopting Veeva software, data, and consulting to accelerate pre-launch planning and digital-first commercial execution. SEATTLE and PLEASANTON, …

See Also: Databases PreviewShow details

WEBRocketreach finds email, phone & social media for 450M+ professionals. Try for free at rocketreach.co Parsippany-Troy Hills, NJ, US. Greg Davies's Work. Director Drug …

See Also: Phone Number PreviewShow details

888-202-6183 WEBThe Debtor established an information line for interested parties: 888-202-6183 (US & Canada toll free) and 747-288-6396 (International). You can also send an email to …

See Also: Home Phone PreviewShow details

Please leave your comments here:

 
ADVERTISEMENT
ADVERTISEMENT

ADVERTISEMENT

Popular Search